CONGENITAL ABSENCE OF CRANIAL VAULT

This adverse event was reported 58 times

These drugs are most commonly taken by patients reporting CONGENITAL ABSENCE OF CRANIAL VAULT:

# Drug Count
0 FLUCONAZOLE 12
1 ALBENDAZOLE 8
2 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 8
3 IVACAFTOR 7
4 PANCRELIPASE 6
5 ENOXAPARIN SODIUM 5
6 ESTRADIOL 5
7 ESTRADIOL GEL 0.1% 5
8 ESTRADIOL TRANSDERMAL 5
9 ESTRADIOL, 5
See all common drugs associated with CONGENITAL ABSENCE OF CRANIAL VAULT

CONGENITAL ABSENCE OF CRANIAL VAULT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALBENDAZOLE 8 0.0042
1 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 8 0.0038
2 COLISTIMETHATE SODIUM 1 0.0006
3 MINOCYCLINE HYDROCHLORIDE 3 0.0005
4 PYRAZINAMIDE 4 0.0004
5 RIFAMPICIN 3 0.0003
6 ATAZANAVIR 3 0.0002
7 ISONIAZID 3 0.0002
8 MINOCYCLINE 2 0.0002
9 FLUCONAZOLE 12 0.0002
See all drugs enriched for association with CONGENITAL ABSENCE OF CRANIAL VAULT

CONGENITAL ABSENCE OF CRANIAL VAULT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 8 0.0028
1 Antimalarial [EPC] 8 0.0008
2 Antiprotozoal [EPC] 8 0.0008
3 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 7 0.0004
4 Antimycobacterial [EPC] 4 0.0002
5 Vitamin K [EPC] 1 0.0001
6 Azole Antifungal [EPC] 12 0.0001
7 Protease Inhibitor [EPC] 3 0.0001
8 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
9 Interleukin-23 Antagonist [EPC] 4 0.0000
See all drug classes enriched for association with CONGENITAL ABSENCE OF CRANIAL VAULT